Disclosures for "Plasma metabolites associated with clinically diagnosed Alzheimer’s Disease and the association is augmented using blood-based biomarkers.")
-
Dr. Kalia has nothing to disclose.
-
Mrs. Reyes-Dumeyer has nothing to disclose.
-
Mr. DUBEY has nothing to disclose.
-
Dr. Nandakumar has nothing to disclose.
-
Dr. Lee has nothing to disclose.
-
Rafael Lantigua has nothing to disclose.
-
Dr. Medrano has nothing to disclose.
-
Dr. Rivera Mejia has nothing to disclose.
-
Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Honig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms . The institution of Dr. Honig has received research support from Roche. The institution of Dr. Honig has received research support from Eisau. Dr. Honig has received research support from Alector. The institution of Dr. Honig has received research support from Transposon.
-
Dr. Mayeux has nothing to disclose.
-
Badri Vardarajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kodikaz Therapeutics.